首页 正文

Postmarketing safety analysis of remimazolam: Identifying unlabelled serious events

{{output}}
Background: Remimazolam is a new ultra-short-acting benzodiazepine used in anaesthesia, valued for its rapid metabolism and reversibility. Despite its growing clinical use, a comprehensive assessment of its real-world safety prof... ...